Credence Research Logo

Home » Healthcare » Pharmaceuticals » Angina Pectoris Treatment Market

Angina Pectoris Treatment Market

Angina Pectoris Treatment Market By Medication Types (Nitroglycerin and Nitrate Medications, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, Statins); By Invasive Procedures (Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)); By Lifestyle Modifications (Dietary Changes, Regular Exercise, Smoking Cessation, Stress Management); By Device-based Therapies (Enhanced External Counterpulsation (EECP), Transcutaneous Electrical Nerve Stimulation (TENS)); By Treatment Settings (Outpatient Care, Inpatient Care, Ambulatory Surgical Centers); By Emerging Therapies (Gene Therapies, Cell Therapies); By Angina Types (Stable Angina, Unstable Angina, Variant (Prinzmetal’s) Angina); By Patient Demographics (Adults, Geriatric Population) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 12801 | Report Format : Excel, PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Angina Pectoris Treatment Market Size 2023  USD 2845.8 Million
Angina Pectoris Treatment Market, CAGR  5.00%
Angina Pectoris Treatment Market Size 2032  USD 4414.78 Million

Market Insights

  • The global Angina Pectoris Treatment Market size was valued at USD 2845.8 Million in 2023 and is projected to reach USD 4414.78 Million in 2032, growing at a CAGR of 5.00% between 2024 and 2032.
  • Among the key segments, the By Medication Types category plays a crucial role, with Nitroglycerin and Nitrate Medications, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, and Statins contributing significantly to the market share. Invasive Procedures such as Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) also play a vital role, along with Lifestyle Modifications and Device-based Therapies like Enhanced External Counterpulsation (EECP) and Transcutaneous Electrical Nerve Stimulation (TENS).
  • Key companies in the Angina Pectoris Treatment market include Abbott, AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, ALLERGAN, Gilead Sciences, Inc., GlaxoSmithKline plc., Novartis AG, Pfizer Inc., Sanofi, and other key players.
  • The market for Angina Pectoris Treatment is driven by the growing prevalence of angina types such as Stable Angina, Unstable Angina, and Variant (Prinzmetal’s) Angina among the adult and geriatric population.
  • Treatment settings encompass Outpatient Care, Inpatient Care, Ambulatory Surgical Centers, with emerging therapies like Gene Therapies and Cell Therapies making strides in the market.
  • North America holds a significant share in the Angina Pectoris Treatment market, contributing to its growth, while Asia-Pacific and Europe collectively account for a substantial portion of the market share.
  • Factors such as lifestyle changes, dietary modifications, regular exercise, smoking cessation, and stress management contribute to the market’s expansion, offering novel possibilities for growth in the Angina Pectoris Treatment market.

Angina Pectoris Treatment Market

Executive Summary

Market Definition

The Angina Pectoris Treatment market focuses on therapeutic approaches that address the symptoms and underlying causes of angina. This comprehensive treatment market includes various medication types such as Nitroglycerin and Nitrate Medications, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, and Statins. Additionally, it incorporates invasive procedures like Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG), lifestyle modifications emphasizing dietary changes, regular exercise, smoking cessation, and stress management, as well as device-based therapies like Enhanced External Counterpulsation (EECP) and Transcutaneous Electrical Nerve Stimulation (TENS). The market extends its scope to different treatment settings, including Outpatient Care, Inpatient Care, and Ambulatory Surgical Centers, catering to the needs of adults and the geriatric population.

Design Element 2

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

CTA Design Element 3

Market Overview

The Angina Pectoris Treatment market has exhibited consistent growth and is projected to maintain a CAGR of 5.00% between 2024 and 2032. Valued at USD 2845.8 million in 2023, the market is anticipated to reach USD 4414.78 million in 2032. The primary growth driver stems from the escalating prevalence of angina types such as Stable Angina, Unstable Angina, and Variant (Prinzmetal’s) Angina. The market addresses the evolving healthcare landscape by offering diverse treatment options, ensuring effective management of angina symptoms and promoting overall well-being.

Factors such as the involvement of key companies including Abbott, AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, ALLERGAN, Gilead Sciences, Inc., GlaxoSmithKline plc., Novartis AG, Pfizer Inc., Sanofi, and other significant players contribute to the market’s robustness. The market’s global reach extends to North America, Asia-Pacific, and Europe, with North America leading the growth trajectory. The market’s expansion is further fueled by emerging therapies like Gene Therapies and Cell Therapies, catering to the diverse needs of the adult and geriatric population seeking effective angina treatment options.

Segmentation by Medication Types

  • Nitroglycerin and Nitrate Medications emerge as the dominant segment, accounting for over 25% share in value in 2023. This can be attributed to the widespread use of these medications for rapid relief from angina symptoms.
  • Beta-Blockers represent a key segment, demonstrating a steady CAGR throughout the forecast period. The sustained demand for beta-blockers in managing angina is a significant factor contributing to their market share growth.
  • Calcium Channel Blockers witness a notable increase in market share, fueled by their efficacy in treating angina by relaxing blood vessels and improving blood flow.
  • Antiplatelet Agents and Statins play crucial roles in preventing complications associated with angina, contributing substantially to the overall market size.

Segmentation by Invasive Procedures

  • Percutaneous Coronary Intervention, commonly known as angioplasty, involves the use of a catheter to open narrowed coronary arteries. It is a leading invasive procedure and holds a significant market share, possibly around 30% in 2023.
  • CABG is a surgical procedure that involves redirecting blood flow around a blocked or narrowed section of the coronary artery. While it may have a lower market share compared to PCI, it still holds a substantial percentage in 2023.

Segmentation by Lifestyle Modifications

  • Dietary modifications are an essential component of angina management, focusing on heart-healthy diets. This segment may have a moderate market share, around 15%, as individuals increasingly recognize the impact of their diet on cardiovascular health.
  • Regular physical activity is crucial in managing angina symptoms. The market share for this segment could be around 10%, as more individuals adopt exercise routines as part of their angina treatment plan further propel the market growth.

Segmentation by Device-based Therapies

  • EECP is a non-invasive therapy that may have a market share of around 5%, gaining popularity due to its effectiveness in improving blood flow and reducing angina symptoms.
  • TENS, as a device-based therapy, might have a prominent market share owing to non-invasive and advancements in technology.

Segmentation by Treatment Settings

  • Outpatient care settings dominate the market, accounting for more than 30% of the overall angina treatment market, showcasing the trend towards managing angina outside of traditional hospital settings.
  • Inpatient care settings, including hospitals, may hold a significant lower market share and in 2023 and are predicted to grow with prominent CAGR.

Segmentation by Emerging Therapies

  • Gene therapies could be an emerging segment with a significant market share, owing to the cutting-edge approaches in treating angina by addressing genetic factors.
  • Cell therapies might also have a market share of around 6%, showcasing innovative approaches using cellular components for angina management.

Segmentation by Angina Types

  • Stable angina may represent the largest segment, with a market share of around 40%, as it is the most common form of angina.
  • Variant angina may have a smaller market share, approximately 10%, as it is a less common form of angina.

Segmentation by Patient Demographics

  • The adult population may constitute the majority, with a market share of around 85%, reflecting the prevalence of angina in this age group. The factors contributed to this segmemt such as Smoking, Emotional stress, and others factors among adult.
  • The geriatric population has significant market share, indicating the importance of addressing angina in older individuals who may have additional health considerations.

Angina Pectoris Treatment Market Size

Segmentation by Region

  • The Angina Pectoris Treatment Market is experiencing substantial growth in North America, contributing to over one-third of the market share in 2023. This growth is attributed to the expansion of healthcare facilities and increased awareness of angina pectoris treatment options. The region is witnessing a rise in healthcare expenditure and advanced medical infrastructure, further fueling market expansion.
  • In Asia Pacific and Europe, the Angina Pectoris Treatment Market collectively accounts for just under 55% share in 2023, with Europe holding over 20% share in 2023. The prevalence of angina cases, coupled with advancements in medical research and healthcare infrastructure, is driving the demand for effective angina pectoris treatments in these regions.
  • The rest of the world, including Latin America, the Middle East, and Africa, contributes to the remaining demand for angina pectoris treatments. Emerging economies in these regions are witnessing a rise in the geriatric population, leading to an increased prevalence of angina cases and subsequently driving the market growth.

The Angina Pectoris Treatment Market is growing due to increasing prevalence of angina pectoris, demand for minimally invasive procedures, and advancements in medical technology.

North America serves as a key region for the Angina Pectoris Treatment Market, showcasing a leadership role in healthcare advancements and innovation. The market in North America is driven by factors such as the presence of major pharmaceutical companies, increased healthcare expenditure, and the widespread adoption of advanced medical technologies. Access to various treatment alternatives is facilitated through the integration of cutting-edge medical interventions and technologies. The region boasts a robust infrastructure for outpatient and inpatient care settings, contributing to the overall growth of the Angina Pectoris Treatment Market.

The Asia Pacific is anticipated to emerge as the fastest-growing region in the Angina Pectoris Treatment Market over the forecast period. A significant factor propelling market expansion in this region is the abundance of pharmaceutical and healthcare companies specializing in cardiovascular treatments. High disposable income and a burgeoning geriatric population further drive the demand for angina pectoris treatments in the Asia Pacific. Government initiatives, such as healthcare schemes and policies promoting cardiovascular health, contribute to the overall growth of the market. For instance, the implementation of initiatives aimed at promoting a healthier lifestyle and cardiovascular health awareness aligns with the market’s growth trajectory.

The primary catalyst for the Angina Pectoris Treatment Market’s growth is the increasing acceptance of diverse treatment modalities, ranging from medication types such as Nitroglycerin and Beta-Blockers to invasive procedures like Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG). Lifestyle modifications, including dietary changes and regular exercise, play a crucial role in managing angina. The market is also influenced by emerging therapies like gene and cell therapies, catering to both adults and the geriatric population.

Key Highlights of the Report

The Angina Pectoris Treatment Market is comprehensively segmented based on medication types, invasive procedures, lifestyle modifications, device-based therapies, treatment settings, emerging therapies, angina types, and patient demographics. Notable segments include Nitroglycerin and Nitrate Medications, are the most popular, while Regular Exercise Smoking Cessation are the primary segments. However, Adults Demographics and Outpatient Care Treatment Settings dominate the market, with North America leading the market growth.

One of the main factors propelling the global market for Angina Pectoris Treatments increasing prevalence of angina pectoris, particularly among the aging global population. Emerging healthcare applications like personalized medicine and targeted therapies create new avenues for the market’s development.

Nonetheless, North America emerges as a significant player in the Angina Pectoris Treatment Market, leading in market growth. The region’s prominence is attributed to ongoing developments in angina pectoris treatment technologies and robust infrastructure. However, the Asia-Pacific (APAC) region is poised to experience the highest growth rate, fueled by the presence of electronics manufacturing firms and an increasing demand for effective data transferability.

What Are The Main Drivers Of The Global Angina Pectoris Treatment Market?

The global Angina Pectoris Treatment Market is experiencing growth due to the increasing prevalence of angina pectoris, particularly among the aging global population. This has led to a rising demand for effective treatment modalities and interventions. Ongoing innovations in treatment, holistic patient care approaches, and industry collaborations among key pharmaceutical and healthcare companies are driving market growth. The market is also influenced by demographic factors, such as the aging population and the unique healthcare needs of adults and the geriatric population.

What Are The Major Challenges Faced By The Global Angina Pectoris TreatmentMarket?

The Angina Pectoris Treatment Market faces several challenges, including economic fluctuations, global commodity costs, and regulatory and certification requirements that can hinder market expansion. The lack of qualified personnel and high treatment costs can also impact market growth.

What Are The Growth Opportunities In The Global Angina Pectoris TreatmentMarket?

The Angina Pectoris Treatment Market presents growth opportunities through the integration of new technologies, such as gene and cell therapies, and advanced diagnostic tools. The expanded use of treatment modalities, including devices for enhanced external counterpulsation (EECP) and transcutaneous electrical nerve stimulation (TENS), offers prospects for market growth. Additionally, emerging healthcare applications like personalized medicine and targeted therapies create new avenues for the market’s development.

Market Drivers

The global angina pectoris treatment market is driven by several factors. The following are the key drivers of the global angina pectoris treatment market:

Increasing Aging Population

The aging population is a significant opportunity of the angina pectoris treatment market. As people age, their risk of developing cardiovascular diseases, including angina pectoris, increases. According to the World Health Organization (WHO), the global population aged 65 and older is projected to reach nearly 2 billion by 2050, which will result in a substantial increase in the demand for angina pectoris treatments. Moreover, advances in medical technology and healthcare services have led to an increased life expectancy, further contributing to the growing prevalence of angina pectoris and the need for effective treatments.

Market Restraints

The global angina pectoris treatment market faces some challenges that may hinder its growth. These include the following:

Economic Factors and Affordability

Economic factors and affordability are significant constraints on the angina pectoris treatment market. The high cost of some treatments, such as drug-eluting stents and coronary artery bypass grafting, can limit accessibility for patients in low-income countries or those with financial limitations. Additionally, the economic burden of chronic disease management can be substantial, leading some patients to forgo necessary treatments due to financial concerns. This has led to a growing interest in more affordable and cost-effective treatment options, such as lifestyle modifications and generic medications.

Opportunities

The global angina pectoris treatment market offers significant growth opportunities. These include the following:

Growing Market Players strategies

Key players in the Angina Pectoris Treatment Market include Lupin,  Pfizer Inc., Sanofi, ZydusTakeda and Otsuka, among others. The market players are considerably contributing to the market growth by adopting various growth strategies including new product launches, mergers and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market. For instance, in May 2020, Takeda and Otsuka launched Cabpirin Combination Tablets, a vonoprazan fumarate and low-dose aspirin combination, in Japan. The drug is indicated for reducing thrombosis/embolism risk in patients with history of gastric/duodenal ulcers and angina, myocardial infarction, ischemic cerebrovascular disease, or after CABG/PTCA. Takeda obtained manufacturing and marketing approval in March 2020. The combination tablet aims to improve patient adherence.

Competitive Landscape

Angina Pectoris Treatment Market Share

Key Players

The global Angina Pectoris Treatment market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Abbott.
  • AstraZeneca
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • ALLERGAN, Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • Novartis AG, Pfizer Inc.
  • Sanofi
  • others

These organizations prioritize product innovation, distribution channel expansion, and mergers and acquisitions to stay competitive.

The global Angina Pectoris Treatment market’s key players continually seek to stay ahead by offering new products and developments.

In September 2020, Abbott received approval from the DCGI for its once-a-day formulation, Ivabradine, used to treat chronic heart failure and chronic stable angina.

In May 2019 , Zydus Cadila received final approval from the USFDA to market generic Ranolazine Extended-Release tablets for chronic angina treatment. The drug will be available in 500 mg and 1,000 mg strengths and may be used with other medications for heart problems and blood pressure control. The tablets will be manufactured at the company’s Baddi facility.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

  • The demand for Angina Pectoris Treatment is increasing due to the rising prevalence of the condition, driving growth in the market for treatment options.
  • Market segmented by Medication Types, Lifestyle Modifications, Device-based Therapies, Treatment Settings, Emerging Therapies, Angina Types, Patient Demographics, and region.
  • Stable Angina is a most common Angina Types occures in the patients.
  • North America is leading market growth; the market is highly competitive with key players including Bristol-Myers Squibb Company, GlaxoSmithKline plc  , Novartis AG  , Pfizer Inc.  , Allergan  , Gilead Sciences, Inc., and others.

Future Outlook

  • Positive outlook for the global Angina Pectoris Treatment market with significant growth potential in the North American region.
  • The Angina Pectoris Treatment market presents a positive outlook globally, with substantial growth potential, particularly in the North American region, driven by advancements in healthcare infrastructure and increased awareness.
  • During the forecast period, consumers’ increasing inclination towards alternative and non-traditional treatment options, including lifestyle modifications, emerging therapies, and holistic approaches, is anticipated to be a significant factor restraining the growth of conventional medication-based treatments.
  • Key firms must focus on product innovation, growing market reach, and maintaining competitive pricing to keep ahead of the competition.

How CXOs Can Benefit from the Credence Research Angina Pectoris Treatment Market Report

The Credence Research Angina Pectoris Treatment Market Report provides CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast:The report provides detailed estimates of the global Angina Pectoris Treatment market size, segmented by fiber type, network type, application, and region. It also includes forecasts for the market through 2032, based on key trends and drivers.
  • Market segmentation:The report segments the Angina Pectoris Treatment market by Medication Types, Lifestyle Modifications, Device-based Therapies, Treatment Settings, Emerging Therapies, Angina Types, Patient Demographics, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive landscape:The report profiles the key players in the Angina Pectoris Treatment market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers:The report identifies and analyzes the key trends and drivers that are shaping the Angina Pectoris Treatment market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Angina Pectoris Treatment Market Report to:

  • Identify growth opportunities:The report can help CXOs to identify new growth opportunities in the Angina Pectoris Treatment market. For example, the report identifies the growing demand for Angina Pectoris Treatment from cloud computing providers and telecom companies as a key opportunity.
  • Make informed investment decisions:The report can help CXOs to make informed investment decisions about Angina Pectoris Treatment. For example, the report provides insights into the key factors to consider when evaluating dark fiber providers and selecting dark fiber solutions.
  • Develop competitive strategies:The report can help CXOs to develop competitive strategies for their Angina Pectoris Treatment businesses. For example, the report identifies the key strategies that dark fiber providers are using to differentiate themselves from their competitors.
  • Track market developments:The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the Angina Pectoris Treatment market.

Overall, the Credence Research Angina Pectoris Treatment Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

  • By Medication Types
    • Nitroglycerin and Nitrate Medications
    • Beta-Blockers
    • Calcium Channel Blockers
    • Antiplatelet Agents
    • Statins
  • By Invasive Procedures:
    • Percutaneous Coronary Intervention (PCI)
    • Coronary Artery Bypass Grafting (CABG)
  • By Lifestyle Modifications
    • Dietary Changes
    • Regular Exercise
    • Smoking Cessation
    • Stress Management
  • By Device-based Therapies
    • Enhanced External Counterpulsation (EECP)
    • Transcutaneous Electrical Nerve Stimulation (TENS)
  • By Treatment Settings
    • Outpatient Care
    • Inpatient Care
    • Ambulatory Surgical Centers
  • By Emerging Therapies
    • Gene Therapies
    • Cell Therapies
  • By Angina Types
    • Stable Angina
    • Unstable Angina
    • Variant (Prinzmetal’s) Angina
  • By Patient Demographics
    • Adults
    • Geriatric Population
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Adjacent Markets

In the Angina Pectoris Treatment market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Angina Pectoris Treatment market –

Angina Pectoris Treatment Market Growth

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Angina Pectoris Treatment Market
2.1.1. Global Angina Pectoris Treatment Market, By Medication Types
2.1.2. Global Angina Pectoris Treatment Market, By Invasive Procedures
2.1.3. Global Angina Pectoris Treatment Market, By Lifestyle Modifications
2.1.4. Global Angina Pectoris Treatment Market, By Device-based Therapies
2.1.5. Global Angina Pectoris Treatment Market, By Treatment Settings
2.1.6. Global Angina Pectoris Treatment Market, By Emerging Therapies
2.1.7. Global Angina Pectoris Treatment Market, By Angina Types
2.1.8. Global Angina Pectoris Treatment Market, By Patient Demographics
2.1.9. Global Angina Pectoris Treatment Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Angina Pectoris Treatment Market Value, 2019-2032, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Wired Drivers
3.2.2. Angina Pectoris Treatment Market Restraints
3.2.3. Angina Pectoris Treatment Market Opportunities
3.2.4. Major Angina Pectoris Treatment Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Medication Types
3.5.2. Invasive Procedures
3.5.3. Lifestyle Modifications
3.5.4. Device-based Therapies
3.5.5. Treatment Settings
3.5.6. Emerging Therapies
3.5.7. Angina Types
3.5.8. Patient Demographics
3.5.9. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2023
4.1.1. Global Angina Pectoris Treatment Market: Company Market Share, Value 2023
4.1.2. Global Angina Pectoris Treatment Market: Top 6 Company Market Share, Value 2023
4.1.3. Global Angina Pectoris Treatment Market: Top 3 Company Market Share, Value 2023
4.2. Global Angina Pectoris Treatment Market: Company Revenue Share Analysis, 2023
4.3. Company Assessment Metrics, 2023
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2023
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Angina Pectoris Treatment Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2023
6.1. Company market share of key players, 2023
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Angina Pectoris Treatment Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Angina Pectoris Treatment Market, By Medication Types
8.1. Global Angina Pectoris Treatment Market Overview, by Medication Types
8.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Medication Types, 2023 Vs 2032 (in %)
8.2. Nitroglycerin and Nitrate Medications
8.2.1. Global Angina Pectoris Treatment Market, By Nitroglycerin and Nitrate Medications, By Region, 2019-2032(US$ Mn)
8.2.2. Market Dynamics for Nitroglycerin and Nitrate Medications
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Beta-Blockers
8.3.1. Global Angina Pectoris Treatment Market, By Beta-Blockers, By Region, 2019-2032 (US$ Mn)
8.3.2. Market Dynamics for Beta-Blockers
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Calcium Channel Blockers
8.4.1. Global Angina Pectoris Treatment Market, By Calcium Channel Blockers, By Region, 2019-2032 (US$ Mn)
8.4.2. Market Dynamics for Calcium Channel Blockers
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Antiplatelet Agents
8.5.1. Global Angina Pectoris Treatment Market, By Antiplatelet Agents, By Region, 2019-2032 (US$ Mn)
8.5.2. Market Dynamics for Antiplatelet Agents
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Statins
8.6.1. Global Angina Pectoris Treatment Market, By Statins, By Region, 2019-2032 (US$ Mn)
8.6.2. Market Dynamics for Statins
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
9. Global Angina Pectoris Treatment Market, By Invasive Procedures
9.1. Global Angina Pectoris Treatment Market Overview, by Invasive Procedures
9.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Invasive Procedures, 2023 Vs 2032 (in %)
9.2. Percutaneous Coronary Intervention (PCI)
9.2.1. Global Angina Pectoris Treatment Market, By Percutaneous Coronary Intervention (PCI), By Region, 2019-2032 (US$ Mn)
9.2.2. Market Dynamics for Percutaneous Coronary Intervention (PCI)
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Coronary Artery Bypass Grafting (CABG)
9.3.1. Global Angina Pectoris Treatment Market, By Coronary Artery Bypass Grafting (CABG), By Region, 2019-2032 (US$ Mn)
9.3.2. Market Dynamics for Coronary Artery Bypass Grafting (CABG)
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Angina Pectoris Treatment Market, By Lifestyle Modifications
10.1. Global Angina Pectoris Treatment Market Overview, by Lifestyle Modifications
10.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Lifestyle Modifications, 2023 Vs 2032 (in %)
10.2. Dietary Changes
10.2.1. Global Angina Pectoris Treatment Market, By Dietary Changes, By Region, 2019-2032 (US$ Mn)
10.2.2. Market Dynamics for Dietary Changes
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Regular Exercise
10.3.1. Global Angina Pectoris Treatment Market, By Regular Exercise, By Region, 2019-2032 (US$ Mn)
10.3.2. Market Dynamics for Regular Exercise
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Smoking Cessation
10.4.1. Global Angina Pectoris Treatment Market, By Smoking Cessation, By Region, 2019-2032 (US$ Mn)
10.4.2. Market Dynamics for Smoking Cessation
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Stress Management
10.5.1. Global Angina Pectoris Treatment Market, By Stress Management, By Region, 2019-2032 (US$ Mn)
10.5.2. Market Dynamics for Stress Management
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
11. Global Angina Pectoris Treatment Market, By Device-based Therapies
11.1. Global Angina Pectoris Treatment Market Overview, by Device-based Therapies
11.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Device-based Therapies, 2023 Vs 2032 (in %)
11.2. Enhanced External Counterpulsation (EECP)
11.2.1. Global Angina Pectoris Treatment Market, By Enhanced External Counterpulsation (EECP), By Region, 2019-2032 (US$ Mn)
11.2.2. Market Dynamics for Enhanced External Counterpulsation (EECP)
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Transcutaneous Electrical Nerve Stimulation (TENS)
11.3.1. Global Angina Pectoris Treatment Market, By Transcutaneous Electrical Nerve Stimulation (TENS), By Region, 2019-2032 (US$ Mn)
11.3.2. Market Dynamics for Transcutaneous Electrical Nerve Stimulation (TENS)
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global Angina Pectoris Treatment Market, By Treatment Settings
12.1. Global Angina Pectoris Treatment Market Overview, by Treatment Settings
12.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Treatment Settings, 2023 Vs 2032 (in %)
12.2. Outpatient Care
12.2.1. Global Angina Pectoris Treatment Market, By Outpatient Care, By Region, 2019-2032 (US$ Mn)
12.2.2. Market Dynamics for Outpatient Care
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Inpatient Care
12.3.1. Global Angina Pectoris Treatment Market, By Inpatient Care, By Region, 2019-2032 (US$ Mn)
12.3.2. Market Dynamics for Inpatient Care
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Ambulatory Surgical Centers
12.4.1. Global Angina Pectoris Treatment Market, By Ambulatory Surgical Centers, By Region, 2019-2032 (US$ Mn)
12.4.2. Market Dynamics for Ambulatory Surgical Centers
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Angina Pectoris Treatment Market, By Emerging Therapies
13.1. Global Angina Pectoris Treatment Market Overview, by Emerging Therapies
13.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Emerging Therapies, 2023 Vs 2032 (in %)
13.2. Gene Therapies
13.2.1. Global Angina Pectoris Treatment Market, By Gene Therapies, By Region, 2019-2032 (US$ Mn)
13.2.2. Market Dynamics for Gene Therapies
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Cell Therapies
13.3.1. Global Angina Pectoris Treatment Market, By Cell Therapies, By Region, 2019-2032 (US$ Mn)
13.3.2. Market Dynamics for Cell Therapies
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
14. Global Angina Pectoris Treatment Market, By Angina Types
14.1. Global Angina Pectoris Treatment Market Overview, by Angina Types
14.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Angina Types, 2023 Vs 2032 (in %)
14.2. Stable Angina
14.2.1. Global Angina Pectoris Treatment Market, By Stable Angina, By Region, 2019-2032 (US$ Mn)
14.2.2. Market Dynamics for Stable Angina
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Unstable Angina
14.3.1. Global Angina Pectoris Treatment Market, By Unstable Angina, By Region, 2019-2032 (US$ Mn)
14.3.2. Market Dynamics for Unstable Angina
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
14.4. Variant (Prinzmetal’s) Angina
14.4.1. Global Angina Pectoris Treatment Market, By Variant (Prinzmetal’s) Angina, By Region, 2019-2032 (US$ Mn)
14.4.2. Market Dynamics for Variant (Prinzmetal’s) Angina
14.4.2.1. Drivers
14.4.2.2. Restraints
14.4.2.3. Opportunities
14.4.2.4. Trends
15. Global Angina Pectoris Treatment Market, By Patient Demographics
15.1. Global Angina Pectoris Treatment Market Overview, by Patient Demographics
15.1.1. Global Angina Pectoris Treatment Market Revenue Share, By Patient Demographics, 2023 Vs 2032 (in %)
15.2. Adults
15.2.1. Global Angina Pectoris Treatment Market, By Adults, By Region, 2019-2032 (US$ Mn)
15.2.2. Market Dynamics for Adults
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Geriatric Population
15.3.1. Global Angina Pectoris Treatment Market, By Geriatric Population, By Region, 2019-2032 (US$ Mn)
15.3.2. Market Dynamics for Geriatric Population
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
16. Global Angina Pectoris Treatment Market, By Region
16.1. Global Angina Pectoris Treatment Market Overview, by Region
16.1.1. Global Angina Pectoris Treatment Market, By Region, 2023 vs 2032 (in%)
16.2. Medication Types
16.2.1. Global Angina Pectoris Treatment Market, By Medication Types, 2019-2032 (US$ Mn)
16.3. Invasive Procedures
16.3.1. Global Angina Pectoris Treatment Market, By Invasive Procedures, 2019-2032 (US$ Mn)
16.4. Lifestyle Modifications
16.4.1. Global Angina Pectoris Treatment Market, By Lifestyle Modifications, 2019-2032 (US$ Mn)
16.5. Device-based Therapies
16.5.1. Global Angina Pectoris Treatment Market, By Device-based Therapies, 2019-2032 (US$ Mn)
16.6. Treatment Settings
16.6.1. Global Angina Pectoris Treatment Market, By Treatment Settings, 2019-2032 (US$ Mn)
16.7. Emerging Therapies
16.7.1. Global Angina Pectoris Treatment Market, By Emerging Therapies, 2019-2032 (US$ Mn)
16.8. Angina Types
16.8.1. Global Angina Pectoris Treatment Market, By Angina Types, 2019-2032 (US$ Mn)
16.9. Patient Demographics
16.9.1. Global Angina Pectoris Treatment Market, By Patient Demographics, 2019-2032 (US$ Mn)
17. North America Angina Pectoris Treatment Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. North America Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. North America Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. North America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. North America Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. North America Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. North America Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. North America Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. North America Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
17.9.1. Overview
17.9.2. SRC Analysis
17.10. North America Angina Pectoris Treatment Market, by Country, 2019-2032(US$ Mn)
17.10.1. North America Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
17.10.2. U.S.
17.10.3. Canada
17.10.4. Mexico
18. Europe Angina Pectoris Treatment Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Europe Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Europe Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Europe Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Europe Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Europe Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Europe Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Europe Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Europe Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
18.9.1. Overview
18.9.2. SRC Analysis
18.10. Europe Angina Pectoris Treatment Market, by Country, 2019-2032 (US$ Mn)
18.10.1. Europe Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
18.10.2. UK
18.10.3. France
18.10.4. Germany
18.10.5. Italy
18.10.6. Spain
18.10.7. Benelux
18.10.8. Russia
18.10.9. Rest of Europe
19. Asia Pacific Angina Pectoris Treatment Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Asia Pacific Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Asia Pacific Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Asia Pacific Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Asia Pacific Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Asia Pacific Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Asia Pacific Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Asia Pacific Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Asia Pacific Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. Asia Pacific Angina Pectoris Treatment Market, by Country, 2019-2032 (US$ Mn)
19.10.1. Asia Pacific Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
19.10.2. China
19.10.3. Japan
19.10.4. India
19.10.5. South Korea
19.10.6. South East Asia
19.10.7. Rest of Asia Pacific
20. Latin America Angina Pectoris Treatment Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Latin America Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Latin America Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Latin America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Latin America Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Latin America Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Latin America Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Latin America Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Latin America Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Latin America Angina Pectoris Treatment Market, by Country, 2019-2032 (US$ Mn)
20.10.1. Latin America Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
20.10.2. Brazil
20.10.3. Argentina
20.10.4. Rest of Latin America
21. Middle East Angina Pectoris Treatment Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Middle East Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Middle East Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Middle East Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Middle East Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Middle East Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Middle East Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Middle East Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Middle East Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Middle East Angina Pectoris Treatment Market, by Country, 2019-2032 (US$ Mn)
21.10.1. Middle East Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
21.10.2. UAE
21.10.3. Saudi Arabia
21.10.4. Rest of Middle East
22. Africa Angina Pectoris Treatment Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Africa Angina Pectoris Treatment Market, by Medication Types, 2019-2032(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2032(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2032(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2032(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Africa Angina Pectoris Treatment Market, by Treatment Settings, 2019-2032(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2032(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Africa Angina Pectoris Treatment Market, by Angina Types, 2019-2032(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Africa Angina Pectoris Treatment Market, by Patient Demographics, 2019-2032(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Africa Angina Pectoris Treatment Market, by Country, 2019-2032 (US$ Mn)
22.10.1. Middle East Angina Pectoris Treatment Market, by Country, 2023 Vs 2032 (in%)
22.10.2. South Africa
22.10.3. Egypt
22.10.4. Rest of Africa
23. Company Profiles
23.1. Abbott.
23.1.1. Company Overview
23.1.2. Products/Services Portfolio
23.1.3. Geographical Presence
23.1.4. SWOT Analysis
23.1.5. Financial Summary
23.1.5.1. Market Revenue and Net Profit (2019-2023)
23.1.5.2. Business Segment Revenue Analysis
23.1.5.3. Geographical Revenue Analysis
23.2. AstraZeneca
23.3. Bayer AG
23.4. Bristol-Myers Squibb Company
23.5. F. Hoffmann-La Roche Ltd
23.6. ALLERGAN
23.7. Gilead Sciences, Inc.
23.8. GlaxoSmithKline plc.
23.9. Novartis AG
23.10. Pfizer Inc.
23.11. Sanofi
24. Research Methodology
24.1. Research Methodology
24.2. Phase I – Secondary Research
24.3. Phase II – Data Modelling
24.3.1. Company Share Analysis Model
24.3.2. Revenue Based Modelling
24.4. Phase III – Primary Research
24.5. Research Limitations
24.5.1. Assumptions
 
List of Figures
FIG. 1 Global Angina Pectoris Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Angina Pectoris Treatment Market Segmentation
FIG. 4 Global Angina Pectoris Treatment Market, by Medication Types, 2023 (US$ Mn)
FIG. 5 Global Angina Pectoris Treatment Market, by Invasive Procedures, 2023 (US$ Mn)
FIG. 6 Global Angina Pectoris Treatment Market, by Lifestyle Modifications, 2023 (US$ Mn)
FIG. 7 Global Angina Pectoris Treatment Market, by Device-based Therapies, 2023 (US$ Mn)
FIG. 8 Global Angina Pectoris Treatment Market, by Treatment Settings, 2023 (US$ Mn)
FIG. 9 Global Angina Pectoris Treatment Market, by Emerging Therapies, 2023 (US$ Mn)
FIG. 10 Global Angina Pectoris Treatment Market, by Angina Types, 2023 (US$ Mn)
FIG. 11 Global Angina Pectoris Treatment Market, by Patient Demographics, 2023 (US$ Mn)
FIG. 12 Global Angina Pectoris Treatment Market, by Geography, 2023 (US$ Mn)
FIG. 13 Attractive Investment Proposition, by Medication Types, 2023
FIG. 14 Attractive Investment Proposition, by Invasive Procedures, 2023
FIG. 15 Attractive Investment Proposition, by Lifestyle Modifications, 2023
FIG. 16 Attractive Investment Proposition, by Device-based Therapies, 2023
FIG. 17 Attractive Investment Proposition, by Treatment Settings, 2023
FIG. 18 Attractive Investment Proposition, by Emerging Therapies, 2023
FIG. 19 Attractive Investment Proposition, by Angina Types, 2023
FIG. 20 Attractive Investment Proposition, by Patient Demographics, 2023
FIG. 21 Attractive Investment Proposition, by Geography, 2023
FIG. 22 Global Market Share Analysis of Key Angina Pectoris Treatment Market Manufacturers, 2023
FIG. 23 Global Market Positioning of Key Angina Pectoris Treatment Market Manufacturers, 2023
FIG. 24 Global Angina Pectoris Treatment Market Value Contribution, By Medication Types, 2023&2032 (Value %)
FIG. 25 Global Angina Pectoris Treatment Market, by Nitroglycerin and Nitrate Medications, Value, 2019-2032 (US$ Mn)
FIG. 26 Global Angina Pectoris Treatment Market, by Beta-Blockers, Value, 2019-2032 (US$ Mn)
FIG. 27 Global Angina Pectoris Treatment Market, by Calcium Channel Blockers, Value, 2019-2032 (US$ Mn)
FIG. 28 Global Angina Pectoris Treatment Market, by Antiplatelet Agents, Value, 2019-2032 (US$ Mn)
FIG. 29 Global Angina Pectoris Treatment Market, by Statins, Value, 2019-2032 (US$ Mn)
FIG. 30 Global Angina Pectoris Treatment Market Value Contribution, By Invasive Procedures, 2023&2032 (Value %)
FIG. 31 Global Angina Pectoris Treatment Market, by Percutaneous Coronary Intervention (PCI), Value, 2019-2032 (US$ Mn)
FIG. 32 Global Angina Pectoris Treatment Market, by Coronary Artery Bypass Grafting (CABG), Value, 2019-2032 (US$ Mn)
FIG. 33 Global Angina Pectoris Treatment Market Value Contribution, By Lifestyle Modifications, 2023&2032 (Value %)
FIG. 34 Global Angina Pectoris Treatment Market, by Dietary Changes, Value, 2019-2032 (US$ Mn)
FIG. 35 Global Angina Pectoris Treatment Market, by Regular Exercise, Value, 2019-2032 (US$ Mn)
FIG. 36 Global Angina Pectoris Treatment Market, by Smoking Cessation, Value, 2019-2032 (US$ Mn)
FIG. 37 Global Angina Pectoris Treatment Market, by Stress Management, Value, 2019-2032 (US$ Mn)
FIG. 38 Global Angina Pectoris Treatment Market Value Contribution, By Device-based Therapies, 2023&2032 (Value %)
FIG. 39 Global Angina Pectoris Treatment Market, by Enhanced External Counterpulsation (EECP), Value, 2019-2032 (US$ Mn)
FIG. 40 Global Angina Pectoris Treatment Market, by Transcutaneous Electrical Nerve Stimulation (TENS), Value, 2019-2032 (US$ Mn)
FIG. 41 Global Angina Pectoris Treatment Market Value Contribution, By Treatment Settings, 2023&2032 (Value %)
FIG. 42 Global Angina Pectoris Treatment Market, by Outpatient Care, Value, 2019-2032 (US$ Mn)
FIG. 43 Global Angina Pectoris Treatment Market, by Inpatient Care, Value, 2019-2032 (US$ Mn)
FIG. 44 Global Angina Pectoris Treatment Market, by Ambulatory Surgical Centers, Value, 2019-2032 (US$ Mn)
FIG. 45 Global Angina Pectoris Treatment Market Value Contribution, By Emerging Therapies, 2023&2032 (Value %)
FIG. 46 Global Angina Pectoris Treatment Market, by Gene Therapies, Value, 2019-2032 (US$ Mn)
FIG. 47 Global Angina Pectoris Treatment Market, by Cell Therapies, Value, 2019-2032 (US$ Mn)
FIG. 48 Global Angina Pectoris Treatment Market Value Contribution, By Angina Types, 2023&2032 (Value %)
FIG. 49 Global Angina Pectoris Treatment Market, by Stable Angina, Value, 2019-2032 (US$ Mn)
FIG. 50 Global Angina Pectoris Treatment Market, by Unstable Angina, Value, 2019-2032 (US$ Mn)
FIG. 51 Global Angina Pectoris Treatment Market, by Variant (Prinzmetal’s) Angina, Value, 2019-2032 (US$ Mn)
FIG. 52 Global Angina Pectoris Treatment Market Value Contribution, By Patient Demographics, 2023&2032 (Value %)
FIG. 53 Global Angina Pectoris Treatment Market, by Adults, Value, 2019-2032 (US$ Mn)
FIG. 54 Global Angina Pectoris Treatment Market, by Geriatric Population, Value, 2019-2032 (US$ Mn)
FIG. 55 North America Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 56 U.S. Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 57 Canada Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 58 Mexico Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 59 Europe Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 60 Germany Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 61 France Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 62 U.K. Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 63 Italy Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 64 Spain Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 65 Benelux Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 66 Russia Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 67 Rest of Europe Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 68 Asia Pacific Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 69 China Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 70 Japan Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 71 India Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 72 South Korea Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 73 South-East Asia Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 74 Rest of Asia Pacific Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 75 Latin America Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 76 Brazil Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 77 Argentina Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 78 Rest of Latin America Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 79 Middle East Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 80 UAE Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 81 Saudi Arabia Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 82 Rest of Middle East Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 83 Africa Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 84 South Africa Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 85 Egypt Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)
FIG. 86 Rest of Africa Angina Pectoris Treatment Market, 2019-2032 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Angina Pectoris Treatment Market
TABLE 2 Global Angina Pectoris Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Angina Pectoris Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Angina Pectoris Treatment Market, by Competitive Benchmarking, 2023
TABLE 5 Global Angina Pectoris Treatment Market, by Geographical Presence Analysis, 2023
TABLE 6 Global Angina Pectoris Treatment Market, by Key Strategies Analysis, 2023
TABLE 7 Global Angina Pectoris Treatment Market, by Nitroglycerin and Nitrate Medications, By Region, 2019-2023 (US$ Mn)
TABLE 8 Global Angina Pectoris Treatment Market, by Nitroglycerin and Nitrate Medications, By Region, 2024-2032 (US$ Mn)
TABLE 9 Global Angina Pectoris Treatment Market, by Beta-Blockers, By Region, 2019-2023 (US$ Mn)
TABLE 10 Global Angina Pectoris Treatment Market, by Beta-Blockers, By Region, 2024-2032 (US$ Mn)
TABLE 11 Global Angina Pectoris Treatment Market, by Calcium Channel Blockers, By Region, 2019-2023 (US$ Mn)
TABLE 12 Global Angina Pectoris Treatment Market, by Calcium Channel Blockers, By Region, 2024-2032 (US$ Mn)
TABLE 13 Global Angina Pectoris Treatment Market, by Antiplatelet Agents, By Region, 2019-2023 (US$ Mn)
TABLE 14 Global Angina Pectoris Treatment Market, by Antiplatelet Agents, By Region, 2024-2032 (US$ Mn)
TABLE 15 Global Angina Pectoris Treatment Market, by Statins, By Region, 2019-2023 (US$ Mn)
TABLE 16 Global Angina Pectoris Treatment Market, by Statins, By Region, 2024-2032 (US$ Mn)
TABLE 17 Global Angina Pectoris Treatment Market, by Percutaneous Coronary Intervention (PCI), By Region, 2019-2023 (US$ Mn)
TABLE 18 Global Angina Pectoris Treatment Market, by Percutaneous Coronary Intervention (PCI), By Region, 2024-2032 (US$ Mn)
TABLE 19 Global Angina Pectoris Treatment Market, by Coronary Artery Bypass Grafting (CABG), By Region, 2019-2023 (US$ Mn)
TABLE 20 Global Angina Pectoris Treatment Market, by Coronary Artery Bypass Grafting (CABG), By Region, 2024-2032 (US$ Mn)
TABLE 21 Global Angina Pectoris Treatment Market, by Dietary Changes, By Region, 2019-2023 (US$ Mn)
TABLE 22 Global Angina Pectoris Treatment Market, by Dietary Changes, By Region, 2024-2032 (US$ Mn)
TABLE 23 Global Angina Pectoris Treatment Market, by Regular Exercise, By Region, 2019-2023 (US$ Mn)
TABLE 24 Global Angina Pectoris Treatment Market, by Regular Exercise, By Region, 2024-2032 (US$ Mn)
TABLE 25 Global Angina Pectoris Treatment Market, by Smoking Cessation, By Region, 2019-2023 (US$ Mn)
TABLE 26 Global Angina Pectoris Treatment Market, by Smoking Cessation, By Region, 2024-2032 (US$ Mn)
TABLE 27 Global Angina Pectoris Treatment Market, by Stress Management, By Region, 2019-2023 (US$ Mn)
TABLE 28 Global Angina Pectoris Treatment Market, by Stress Management, By Region, 2024-2032 (US$ Mn)
TABLE 29 Global Angina Pectoris Treatment Market, by Enhanced External Counterpulsation (EECP), By Region, 2019-2023 (US$ Mn)
TABLE 30 Global Angina Pectoris Treatment Market, by Enhanced External Counterpulsation (EECP), By Region, 2024-2032 (US$ Mn)
TABLE 31 Global Angina Pectoris Treatment Market, by Transcutaneous Electrical Nerve Stimulation (TENS), By Region, 2019-2023 (US$ Mn)
TABLE 32 Global Angina Pectoris Treatment Market, by Transcutaneous Electrical Nerve Stimulation (TENS), By Region, 2024-2032 (US$ Mn)

TABLE 33 Global Angina Pectoris Treatment Market, by Outpatient Care, By Region, 2019-2023 (US$ Mn)
TABLE 34 Global Angina Pectoris Treatment Market, by Outpatient Care, By Region, 2024-2032 (US$ Mn)
TABLE 35 Global Angina Pectoris Treatment Market, by Inpatient Care, By Region, 2019-2023 (US$ Mn)
TABLE 36 Global Angina Pectoris Treatment Market, by Inpatient Care, By Region, 2024-2032 (US$ Mn)
TABLE 37 Global Angina Pectoris Treatment Market, by Ambulatory Surgical Centers, By Region, 2019-2023 (US$ Mn)
TABLE 38 Global Angina Pectoris Treatment Market, by Ambulatory Surgical Centers, By Region, 2024-2032 (US$ Mn)
TABLE 39 Global Angina Pectoris Treatment Market, by Gene Therapies, By Region, 2019-2023 (US$ Mn)
TABLE 40 Global Angina Pectoris Treatment Market, by Gene Therapies, By Region, 2024-2032 (US$ Mn)
TABLE 41 Global Angina Pectoris Treatment Market, by Cell Therapies, By Region, 2019-2023 (US$ Mn)
TABLE 42 Global Angina Pectoris Treatment Market, by Cell Therapies, By Region, 2024-2032 (US$ Mn)
TABLE 43 Global Angina Pectoris Treatment Market, by Stable Anginas, By Region, 2019-2023 (US$ Mn)
TABLE 44 Global Angina Pectoris Treatment Market, by Stable Angina, By Region, 2024-2032 (US$ Mn)
TABLE 45 Global Angina Pectoris Treatment Market, by Unstable Angina, By Region, 2019-2023 (US$ Mn)
TABLE 46 Global Angina Pectoris Treatment Market, by Unstable Angina, By Region, 2024-2032 (US$ Mn)
TABLE 47 Global Angina Pectoris Treatment Market, by Variant (Prinzmetal’s) Angina, By Region, 2019-2023 (US$ Mn)
TABLE 48 Global Angina Pectoris Treatment Market, by Variant (Prinzmetal’s) Angina, By Region, 2024-2032 (US$ Mn)
TABLE 49 Global Angina Pectoris Treatment Market, by Adults, By Region, 2019-2023 (US$ Mn)
TABLE 50 Global Angina Pectoris Treatment Market, by Adults, By Region, 2024-2032 (US$ Mn)
TABLE 51 Global Angina Pectoris Treatment Market, by Geriatric Population, By Region, 2019-2023 (US$ Mn)
TABLE 52 Global Angina Pectoris Treatment Market, by Geriatric Population, By Region, 2024-2032 (US$ Mn)
TABLE 53 Global Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 54 Global Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 55 Global Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 56 Global Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 57 Global Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 58 Global Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 59 Global Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 60 Global Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 61 Global Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 62 Global Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 63 Global Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 64 Global Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 65 Global Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 66 Global Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 67 Global Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 68 Global Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 69 Global Angina Pectoris Treatment Market, by Region, 2019-2023 (US$ Mn)
TABLE 70 Global Angina Pectoris Treatment Market, by Region, 2024-2032 (US$ Mn)
TABLE 71 North America Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 72 North America Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 73 North America Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 74 North America Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 75 North America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 76 North America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 77 North America Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 78 North America Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 79 North America Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 80 North America Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 81 North America Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 82 North America Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 83 North America Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 84 North America Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 85 North America Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 86 North America Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 87 North America Angina Pectoris Treatment Market, by Country, 2019-2023 (US$ Mn)
TABLE 88 North America Angina Pectoris Treatment Market, by Country, 2024-2032 (US$ Mn)
TABLE 89 United States Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 90 United States Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 91 United States Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 92 United States Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 93 United States Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 94 United States Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 95 United States Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 96 United States Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 97 United States Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 98 United States Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 99 United States Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 100 United States Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 101 United States Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 102 United States Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 103 United States Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 104 United States Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 105 Canada Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 106 Canada Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 107 Canada Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 108 Canada Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 109 Canada Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 110 Canada Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 111 Canada Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 112 Canada Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 113 Canada ca Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 114 Canada Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 115 Canada Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 116 Canada Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 117 Canada Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 118 Canada Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 119 Canada Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 120 Canada Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 121 Mexico Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 122 Mexico Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 123 Mexico Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 124 Mexico Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 125 Mexico Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 126 Mexico Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 127 Mexico Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 128 Mexico Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 129 Mexico Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 130 Mexico Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 131 Mexico Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 132 Mexico Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 133 Mexico Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 134 Mexico Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 135 Mexico Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 136 Mexico Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 137 Europe Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 138 Europe Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 139 Europe Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 140 Europe Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 141 Europe Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 142 Europe Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 143 Europe Angina Pectoris Treatment Market, by Country, 2019-2023 (US$ Mn)
TABLE 144 Europe Angina Pectoris Treatment Market, by Country, 2024-2032 (US$ Mn)
TABLE 145 Europe Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 146 Europe Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 147 Europe Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 148 Europe Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 149 Europe Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 150 Europe Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 151 Europe Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 152 Europe Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 153 Europe Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 154 Europe Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 155 Germany Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 156 Germany Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 157 Germany Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 158 Germany Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 159 Germany Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 160 Germany Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 161 Germany Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 162 Germany Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 163 Germany Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 164 Germany Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 165 Germany Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 166 Germany Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 167 Germany Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 168 Germany Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 169 Germany Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 170 France Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 171 France Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 172 France Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 173 France Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 174 France Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 175 France Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 176 France Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 177 France Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 178 France Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 179 France Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 180 France Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 181 France Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 182 France Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 183 France Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 184 France Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 185 France Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 186 United Kingdom Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 187 United Kingdom Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 188 United Kingdom Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 189 United Kingdom Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 190 United Kingdom Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 191 United Kingdom Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 192 United Kingdom Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 193 United Kingdom Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 194 United Kingdom Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 195 United Kingdom Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 196 United Kingdom Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 197 United Kingdom Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 198 United Kingdom Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 199 United Kingdom Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 200 United Kingdom Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 201 United Kingdom Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 202 Italy Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 203 Italy Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 204 Italy Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 205 Italy Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 206 Italy Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 207 Italy Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 208 Italy Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 209 Italy Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 210 Italy Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 211 Italy Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 212 Italy Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 213 Italy Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 214 Italy Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 215 Italy Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 216 Italy Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 217 Italy Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 218 Spain Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 219 Spain Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 220 Spain Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 221 Spain Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 222 Spain Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 223 Spain Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 224 Spain Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 225 Spain Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 226 Spain Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 227 Spain Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 228 Spain Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 229 Spain Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 230 Spain Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 231 Spain Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 232 Spain Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 233 Spain Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 234 Benelux Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 235 Benelux Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 236 Benelux Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 237 Benelux Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 238 Benelux Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 239 Benelux Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 240 Benelux Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 241 Benelux Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 242 Benelux Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 243 Benelux Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 244 Benelux Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 245 Benelux Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 246 Benelux Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 247 Benelux Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 248 Benelux Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 249 Benelux Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 250 Russia Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 251 Russia Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 252 Russia Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 253 Russia Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 254 Russia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 255 Russia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 256 Russia Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 257 Russia Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 258 Russia Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 259 Russia Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 260 Russia Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 261 Russia Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 262 Russia Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 263 Russia Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 264 Russia Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 265 Russia Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 266 Rest of Europe Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 267 Rest of Europe Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 268 Rest of Europe Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 269 Rest of Europe Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 270 Rest of Europe Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 271 Rest of Europe Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 272 Rest of Europe Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 273 Rest of Europe Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 274 Rest of Europe Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 275 Rest of Europe Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 276 Rest of Europe Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 277 Rest of Europe Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 278 Rest of Europe Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 279 Rest of Europe Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 280 Rest of Europe Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 281 Rest of Europe Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 282 Asia Pacific Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 283 Asia Pacific Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 284 Asia Pacific Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 285 Asia Pacific Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 286 Asia Pacific Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 287 Asia Pacific Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 288 Asia Pacific Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 289 Asia Pacific Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 290 Asia Pacific Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 291 Asia Pacific Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 292 Asia Pacific Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 293 Asia Pacific Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 294 Asia Pacific Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 295 Asia Pacific Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 296 Asia Pacific Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 297 Asia Pacific Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 298 China Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 299 China Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 300 China Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 301 China Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 302 China Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 303 China Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 304 China Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 305 China Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 306 China Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 307 China Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 308 China Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 309 China Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 310 China Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 311 China Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 312 China Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 313 China Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 314 Japan Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 315 Japan Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 316 Japan Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 317 Japan Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 318 Japan Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 319 Japan Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 320 Japan Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 321 Japan Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 322 Japan Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 323 Japan Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 324 Japan Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 325 Japan Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 326 Japan Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 327 Japan Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 328 Japan Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 329 Japan Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 330 India Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 331 India Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 332 India Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 333 India Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 334 India Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 335 India Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 336 India Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 337 India Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 338 India Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 339 India Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 340 India Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 341 India Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 342 India Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 343 India Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 344 India Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 345 India Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 346 South Korea Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 347 South Korea Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 348 South Korea Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 349 South Korea Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 350 South Korea Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 351 South Korea Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 352 South Korea Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 353 South Korea Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 354 South Korea Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 355 South Korea Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 356 South Korea Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 357 South Korea Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 358 South Korea Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 359 South Korea Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 360 South Korea Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 361 South Korea Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 362 South-East Asia Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 363 South-East Asia Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 364 South-East Asia Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 365 South-East Asia Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 366 South-East Asia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 367 South-East Asia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 368 South-East Asia Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 369 South-East Asia Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 370 South-East Asia Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 371 South-East Asia Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 372 South-East Asia a Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 373 South-East Asia Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 374 South-East Asia Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 375 South-East Asia Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 376 South-East Asia Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 377 South-East Asia Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 378 Rest of Asia Pacific Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 379 Rest of Asia Pacific Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 380 Rest of Asia Pacific Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 381 Rest of Asia Pacific Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 382 Rest of Asia Pacific Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 383 Rest of Asia Pacific Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 384 Rest of Asia Pacific Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 385 Rest of Asia Pacific Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 386 Rest of Asia Pacific Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 387 Rest of Asia Pacific Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 388 Rest of Asia Pacific Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 389 Rest of Asia Pacific Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 390 Rest of Asia Pacific Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 391 Rest of Asia Pacific Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 392 Rest of Asia Pacific Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 393 Rest of Asia Pacific Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 394 Latin America Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 395 Latin America Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 396 Latin America Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 397 Latin America Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 398 Latin America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 399 Latin America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 400 Latin America Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 401 Latin America Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 402 Latin America Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 403 Latin America Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 404 Latin America Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 405 Latin America Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 406 Latin America Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 407 Latin America Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 408 Latin America Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 409 Latin America Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 410 Brazil Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 411 Brazil Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 412 Brazil Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 413 Brazil Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 414 Brazil Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 415 Brazil Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 416 Brazil Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 417 Brazil Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 418 Brazil Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 419 Brazil Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 420 Brazil Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 421 Brazil Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 422 Brazil Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 423 Brazil Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 424 Brazil Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 425 Brazil Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 426 Argentina Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 427 Argentina Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 428 Argentina Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 429 Argentina Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 430 Argentina Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 431 Argentina Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 432 Argentina Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 433 Argentina Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 434 Argentina Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 435 Argentina Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 436 Argentina Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 437 Argentina Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 438 Argentina Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 439 Argentina Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 440 Argentina Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 441 Argentina Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 442 Rest of Latin America Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 443 Rest of Latin America Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 444 Rest of Latin America Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 445 Rest of Latin America Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 446 Rest of Latin America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 447 Rest of Latin America Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 448 Rest of Latin America Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 449 Rest of Latin America Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 450 Rest of Latin America Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 451 Rest of Latin America Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 452 Rest of Latin America Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 453 Rest of Latin America Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 454 Rest of Latin America Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 455 Rest of Latin America Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 456 Rest of Latin America Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 457 Rest of Latin America Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 458 Middle East Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 459 Middle East Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 460 Middle East Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 461 Middle East Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 462 Middle East Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 463 Middle East Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 464 Middle East Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 465 Middle East Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 466 Middle East rica Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 467 Middle East Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 468 Middle East Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 469 Middle East Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 470 Middle East Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 471 Middle East Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 472 Middle East Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 473 Middle East Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 474 UAE Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 475 UAE Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 476 UAE Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 477 UAE Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 478 UAE Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 479 UAE Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 480 UAE Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 481 UAE Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 482 UAE Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 483 UAE Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 484 UAE Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 485 UAE Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 486 UAE Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 487 UAE Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 488 UAE Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 489 UAE Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 490 Saudi Arabia Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 491 Saudi Arabia Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 492 Saudi Arabia Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 493 Saudi Arabia Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 494 Saudi Arabia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 495 Saudi Arabia Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 496 Saudi Arabia Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 497 Saudi Arabia Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 498 Saudi Arabia Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 499 Saudi Arabia Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 500 Saudi Arabia Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 501 Saudi Arabia Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 502 Saudi Arabia Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 503 Saudi Arabia Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 504 Saudi Arabia Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 505 Saudi Arabia Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 506 Rest of Middle East Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 507 Rest of Middle East Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 508 Rest of Middle East Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 509 Rest of Middle East Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 510 Rest of Middle East Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 511 Rest of Middle East Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 512 Rest of Middle East Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 513 Rest of Middle East Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 514 Rest of Middle East Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 515 Rest of Middle East Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 516 Rest of Middle East Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 517 Rest of Middle East Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 518 Rest of Middle East Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 519 Rest of Middle East Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 520 Rest of Middle East Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 521 Rest of Middle East Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 522 Africa Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 523 Africa Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 524 Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 525 Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 526 Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 527 Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 528 Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 529 Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 530 Africa Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 531 Africa Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 532 Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 533 Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 534 Africa Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 535 Africa Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 536 Africa Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 537 Africa Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

TABLE 538 South Africa Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 539 South Africa Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 540 South Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 541 South Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 542 South Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 543 South Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 544 South Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 545 South Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 546 South Africa Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 547 South Africa Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 548 South Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 549 South Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 550 South Africa Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 551 South Africa Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 552 South Africa Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 553 South Africa Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)
TABLE 554 Egypt Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 555 Egypt Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 556 Egypt Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 557 Egypt Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 558 Egypt Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 559 Egypt Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 560 Egypt Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 561 Egypt Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 562 Egypt Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 563 Egypt Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 564 Egypt Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 565 Egypt Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 566 Egypt Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 567 Egypt Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 568 Egypt Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 569 Rest of Africa Angina Pectoris Treatment Market, by Medication Types, 2019-2023 (US$ Mn)
TABLE 570 Rest of Africa Angina Pectoris Treatment Market, by Medication Types, 2024-2032 (US$ Mn)
TABLE 571 Rest of Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2019-2023 (US$ Mn)
TABLE 572 Rest of Africa Angina Pectoris Treatment Market, by Invasive Procedures, 2024-2032 (US$ Mn)
TABLE 573 Rest of Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2019-2023 (US$ Mn)
TABLE 574 Rest of Africa Angina Pectoris Treatment Market, by Lifestyle Modifications, 2024-2032 (US$ Mn)
TABLE 575 Rest of Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2019-2023 (US$ Mn)
TABLE 576 Rest of Africa Angina Pectoris Treatment Market, by Device-based Therapies, 2024-2032 (US$ Mn)
TABLE 577 Rest of Africa Angina Pectoris Treatment Market, by Treatment Settings, 2019-2023 (US$ Mn)
TABLE 578 Rest of Africa Angina Pectoris Treatment Market, by Treatment Settings, 2024-2032 (US$ Mn)
TABLE 579 Rest of Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2019-2023 (US$ Mn)
TABLE 580 Rest of Africa Angina Pectoris Treatment Market, by Emerging Therapies, 2024-2032 (US$ Mn)
TABLE 581 Rest of Africa Angina Pectoris Treatment Market, by Angina Types, 2019-2023 (US$ Mn)
TABLE 582 Rest of Africa Angina Pectoris Treatment Market, by Angina Types, 2024-2032 (US$ Mn)
TABLE 583 Rest of Africa Angina Pectoris Treatment Market, by Patient Demographics, 2019-2023 (US$ Mn)
TABLE 584 Rest of Africa Angina Pectoris Treatment Market, by Patient Demographics, 2024-2032 (US$ Mn)

Frequently Asked Questions

What is the current size of the global Angina Pectoris Treatment market?

The global Angina Pectoris Treatment market was valued at USD 2845.8 Million in 2023.

What is the expected growth rate of the Angina Pectoris Treatment market between 2024 and 2032?

The Angina Pectoris Treatment market is expected to grow at a CAGR of 5.0% between 2024 and 2032, reaching USD 4414.76 Million in 2032.

Which segment is leading the market share in terms of Patient Demographics ?

Adults is the leading segment by interface type, holding arround 85% share in value in 2023.

Which Emerging Therapies segment governs the demand for Angina Pectoris Treatment in the world?

The Gene Therapies segment governs the demand for Angina Pectoris Treatments globally.

Which Medication Types segment is expected to post the highest CAGR during the forecast period?

The Nitroglycerin and Nitrate Medications segment, is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the Angina Pectoris Treatment industry?

North America is fueling the growth of the Angina Pectoris Treatment industry, with over one-third share in 2023.

Who are the major players in the global Angina Pectoris Treatment market?

The top players include Abbott., AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, ALLERGAN, Gilead Sciences, Inc., GlaxoSmithKline plc., Novartis AG, Pfizer Inc., Sanofi and Others.

What are the major market drivers of the Angina Pectoris Treatment industry?

The rising cases of heart-related disorders, such as coronary artery disease, diabetes, and hypertension, along with family history, contribute to the growth of the angina pectoris treatment market.

What are the major market restraints of the Angina Pectoris Treatment industry?

The market growth for angina pectoris treatment is hindered by the side effects associated with certain drugs used for the condition. Some of the prominent side effects such Beta Blockers, these drugs can cause fatigue, dizziness, and heart failure in some patients.

What are the major market opportunities of the Angina Pectoris Treatment industry?

In June 2023, according to the National Library of Medicine study estimated that globally, ischemic heart disease,(IHD) also known as Angina Pectoris disease affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the world’s population. Nine million deaths were caused by IHD globally likely to drive the demand for angina pectoris drugs, presenting a significant market opportunity.

Related Reports By Keyword

Prinzmetal Angina Therapeutics Market

Published:
Report ID: 72626

Unstable Angina Therapeutics Market

Published:
Report ID: 70644

Mobile Cardiac Telemetry Systems Market

Published:
Report ID: 8771

Related Reports

Veterinary Wound Cleansers Market

Published:
Report ID: 92696

Synthetic Lethality-based Drugs and Targets Market

Published:
Report ID: 89704

Asia Pacific Retail Pharmacy Market

Published:
Report ID: 91707

Vietnam Retail Pharmacy Market

Published:
Report ID: 91594

India Retail Pharmacy Market

Published:
Report ID: 91335

UK Retail Pharmacy Market

Published:
Report ID: 91320

Japan Retail Pharmacy Market

Published:
Report ID: 91221

Latin America Retail Pharmacy Market

Published:
Report ID: 90852

Australia Retail Pharmacy Market

Published:
Report ID: 90860

Africa Retail Pharmacy Market

Published:
Report ID: 90698

Germany Retail Pharmacy Market

Published:
Report ID: 90666

Middle East Retail Pharmacy Market

Published:
Report ID: 90441

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Let us help you

Credence Staff 3

MIKE, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Smallform of Sample request

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN

Request Sample